GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer
Article in International Journal of Molecular Sciences (June 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in International Journal of Molecular Sciences (June 2023)
Preprint in bioRxiv (February 2023)
Article in Diagnostics (November 2022)